Issue
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review
Corresponding Author(s) : W Li
Cellular and Molecular Biology,
Vol. 61 No. 5: Issue 5
Abstract
The development of advanced molecular technologies has ushered in the era of ‘omics' science, including transcriptomics, proteomics, and genomics. Genomics, or whole genome approach, has become the most comprehensive investigative method to identify new gene mutations, signal pathways and drug targets for cancers. The purpose of this review is to summarize current second generation sequencing techniques in applied genomics, and to analyze the advantages and/or problems associated with each of the various sequencing platforms. Our understanding of molecular factors associated with tumorigenesis is no longer limited to the mutation of well-known cancer related genes, but may involve a broader range of factors involved in tumor development, including novel somatic mutations, gene fusions, long non-coding RNAs, microRNAs, copy number variations, methylation, and genomic structural variations. Furthermore, these new methods are not limited to analyses of single genetic or epigenetic factor, but offer comprehensive molecule profiling as a more critical and powerful approach to decoding the mystery of tumor development and identifying more reliable cancer biomarkers.
Keywords
Next generation sequencing
de novo assembly
whole genome sequencing
whole exome sequencing
gene mutation
biomarker.
Li, W., Zhao, K., Kirberger, M., Liao, W., & Yan, Y. (2015). Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review. Cellular and Molecular Biology, 61(5), 91–102. Retrieved from https://cellmolbiol.org/index.php/CMB/article/view/713
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX